Shares of Jaguar Health Inc (NASDAQ:JAGX) shot up 5.9% during mid-day trading on Wednesday . The stock traded as high as $0.19 and last traded at $0.18. 5,682,818 shares traded hands during mid-day trading, an increase of 7% from the average session volume of 5,293,302 shares. The stock had previously closed at $0.17.
Several research firms recently commented on JAGX. ValuEngine lowered Jaguar Health from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. HC Wainwright reissued a “buy” rating on shares of Jaguar Health in a report on Monday, April 15th.
The company has a quick ratio of 0.18, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
See Also: Systematic Risk
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.